There are public biotech companies with ~$10B valuations and higher price/sales ratios: https://finviz.com/screener.ashx?v=121&f=cap_midover&o=-ps
And private valuations are much more generous than public valuations
Amazing, thanks! I will update the post appropriately.
There are public biotech companies with ~$10B valuations and higher price/sales ratios: https://finviz.com/screener.ashx?v=121&f=cap_midover&o=-ps
And private valuations are much more generous than public valuations
Amazing, thanks! I will update the post appropriately.